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Edited by Christian GriesingerAbstract PrsA is a peptidyl-prolyl isomerase (PPIase) from
Bacillus subtilis belonging to the parvulin family of PPIases.
It is a membrane bound lipoprotein at the membrane–wall
interface, involved in folding of exported proteins. We present
the NMR solution structure of the PPIase domain of PrsA,
the ﬁrst from a Gram-positive bacterium. In addition we
mapped out the active site with NMR titration experiments.
A high degree of conservation with other members of the parv-
ulin family was revealed in the structure and binding site.
Interactions with substrate peptides were also characterized
by mutated domains revealing that H122 is indispensable for
overall correct folding.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Peptidyl-prolyl isomerases (PPIases) are a class of enzymes
which catalyze the rate-limiting step of the cis/trans isomeriza-
tion in protein folding. So far, three structurally distinct PPI-
ase subfamilies have been characterized, the cyclophilins, the
FK506-binding proteins (FKBPs) and the parvulins.
PrsA is an essential membrane bound lipoprotein at the
membrane–wall interface of Bacillus subtilis, exhibiting PPIase
activity [1]. PrsA and its homologues in Gram-positive bacteria
assist the folding of secreted proteins and the extracytoplasmic
domains of some integral membrane proteins involved in the
synthesis of cell wall matrix [2].
PrsA contains three distinctive domains, the PPIase do-
main ﬂanked by N- and C-terminal domains. All these do-
mains are indispensable in vivo [1]. At the amino acid
level, the PPIase domain of PrsA (PrsA-PPI) exhibits 40–Abbreviations:HSQC, heteronuclear single quantum coherence; NMR,
nuclear magnetic resonance; NOESY, nuclear overhauser enhance-
ment spectroscopy; PDB, protein data bank; PPIase, peptidyl-prolyl
cis/trans isomerase; PrsA-PPIase, PPIase domain of PrsA; RMSD,
root mean square deviation; wt, wild type
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comparison of the ﬂanking domains reveals homology to
the PrsA-like proteins of other Gram-positive bacteria, but
not to the other parvulin proteins [2]. The function of these
terminal domains is unknown, but it has been suggested that
they may play a role in multimerization and protein–protein
interactions [1].
Diﬀerences in substrate speciﬁcity indicate that two subfam-
ilies exist within the parvulin family of PPIases. One subfamily
has varying substrate speciﬁcity and the cellular functions are
poorly characterized. Human Par14 (hPar14) and the bacterial
parvulins belong to this family. The other subfamily preferring
phosphorylated substrates includes, e.g., human Pin1 (hPin1),
Ess1 from S. cerevisiae and some plant parvulins. Eukaryotic
parvulins of this subfamily are involved in the regulation of
phosphorylation-dependent cell signalling. For instance, hPin1
aﬀects mitotic cell cycle control, transcriptional regulation and
signal transduction pathways [3,4].
To date, six 3D-structures from both eukaryotic and pro-
karyotic parvulins have been solved with representative struc-
tures from both subfamilies [5–12]. Although they all share the
ba3bab2 parvulin fold, the subfamily preferring phosphory-
lated substrates possesses a speciﬁc loop containing posi-
tively-charged residues interacting with the substrate.
PrsA-PPI can be separately expressed and puriﬁed. Its native
conformation and enzymatic PPIase activity in vitro has been
demonstrated [1]. Here we describe the solution nuclear mag-
netic resonance (NMR) structure of PrsA-PPI and its interac-
tion interface with substrate peptides. Substrate binding was
further characterized with mutated domains.2. Materials and methods
2.1. Protein expression and puriﬁcation
Expression and puriﬁcation of wild type (residues 116–206) and mu-
tated (H122A and D154A) PrsA-PPIs have been described previously
[1]. 15N- and 13C/15N-labelled proteins were puriﬁed from cells grown
in M9 medium containing either 15NH4Cl as the sole nitrogen source
or (13C6)D-glucose and
15NH4Cl as the sole carbon and nitrogen
sources, respectively. After induction with 1 mM isopropyl-beta-D-
thiogalactopyranoside, labelled cells were grown for six additional
hours. For NMR samples the protein was prepared to 20 mM Bis–Tris
buﬀer containing 8% D2O/92% H2O at pH 7.0.2.2. PPIase assay
A protease-coupled assay with a-chymotrypsin was carried out as
described in [13].blished by Elsevier B.V. All rights reserved.
Table 1
NMR restraints and structural statistics for the ensemble of 15 best
conformers of PrsA-PPI
NMR restraints
Total distance restraints 1446
Intraresidual 416
Sequential |i  j| = 1 349
Medium-range, 1 < |i  j| < 5 194
Long-range, |i  j| P 5 487
Restraints per residue 15.9
Violation statistics
Maximum NOE restraint violation (A˚) 0.11
Number of NOE violations >0.10 A˚ 2
Energies
Average restraint violation energy (kcal/mol) 2.93 ± 0.43
Average AMBER energy (kcal/mol) 3144.51 ± 7.94
RMS deviations from ideal covalent geometry
Bond lengths (A˚) 0.0098 ± 0.0001
Bond angles () 1.91 ± 0.02
Atomic coordinate RMSD (A˚)
Backbone atoms 0.43 ± 0.09
Heavy atoms 0.78 ± 0.10
Ramachandran map regions (%)
Residues in most favoured regions 93.5
Additionally allowed regions 6.5
Generously allowed regions 0.0
Disallowed regions 0.0
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NMR spectra were acquired at 25 C on Varian Unity Inova 600
and 800 MHz spectrometers, processed with Vnmr (Varian Inc., Palo
Alto, CA), and analyzed with Sparky [22]. HNCA, HN(CO)CA, iHN-
CA, HNCACB, CBCA(CO)NH, iHNCACB, HN(CA)CO, and
HNCO were utilized in backbone assignment [14], H(CCO)NH,
CC(CO)NH and HCCH-COSY in aliphatic sidechain assignment,
and a combination of (Hb)Cb(CcCd)Hd, (Hb)Cb(CcCdCe)He [15],
and NOE spectra in aromatic sidechain assignment. The assigned res-
onances have been deposited in the BioMagResBank with accession
code 6601.
Distance restraints were retrieved from 15N-separated nuclear over-
hauser enhancement spectroscopy-heteronuclear single quantum
coherence (NOESY-HSQC) and 13C-separated NOESY-HSQC spec-
tra. Structures were generated automatically with CYANA [16] start-
ing with 300 initial conformers. The 30 lowest-energy conformers
were subjected to restrained energy minimization with AMBER [17]
starting with an initial energy minimization followed by a cycle of sim-
ulated annealing using the generalized Born implicit solvent model.
Structures were analyzed with PROCHECK-NMR [18]. A ﬁnal family
of 15 structures with the lowest AMBER energies and best satisfying
the restraints was selected to represent the structure of PrsA-PPI [pro-
tein data bank (PDB) ID 1zk6]. All structure ﬁgures were generated
with MOLMOL [19].
2.4. Mapping of the interaction surface
The three tetrapeptides (Suc-A-K/Y/N-P-F-pNA where Suc and
pNA designate succinyl and p-nitroanilide, respectively) used in the
study were either purchased from Bachem (Bubendorf, Switzerland)
or synthesized at the University of Kuopio (Kuopio, Finland).
From a series of 1H, 15N-HSQC spectra acquired from samples with
PrsA-PPI to peptide molar ratios of 1:0.25, 1:0.5, 1:0.75 1:1, 1:2, 1:4,
1:8, and 1:16 for Suc-AKPF-pNA, and 1:4, 1:8, 1:16 for Suc-ANPF-
pNA and Suc-AYPF-pNA an average chemical shift change was calcu-
lated with
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðdHNÞ2 þ ð0:17 ðdNHÞÞ2
q
. Dissociation constants were
determined by ﬁtting with non-linear regression the average chemical
shift change of all non-overlapping residues versus peptide concentra-
tion to the equation:
dDav ¼ dDmaxfðKD þ ½L0 þ ½P 0Þ

ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðKD þ ½L0 þ ½P 0Þ2  4½L0½P 0
q
g=2½P 0;
where dDav is the average chemical shift change, dDmax the total chem-
ical shift change at saturation, [L0] and [P0] the ligand and protein con-
centrations, respectively.3. Results and discussion
3.1. Structure determination
The structure of B. subtilis PrsA-PPI was determined with
the automated structure calculation program CYANA [16],
and energy-minimized with AMBER [17]. A well-deﬁned
ensemble of structures was obtained (Table 1, Fig. 1) with a
root mean square deviation (RMSD) from the mean coordi-
nates for backbone atoms of 0.43 A˚ and for all heavy atoms
of 0.78 A˚. Somewhat less precise regions are observed at resi-
dues 169–173, 156 and 184–196. The ﬁrst stretch exhibits a
smaller number of NOEs and decreased main chain 15N relax-
ation time ratios (data not shown) indicating increased internal
mobility whereas the latter two regions undergo chemical ex-
change since the T1/T2 ratios are higher than average. The
cross peak of S155 is missing from the 1H, 15N-HSQC spectra,
probably due to extreme broadening.
3.2. Structure description
PrsA-PPI folds into an aba sandwich structure (Fig. 1)
consisting of three a-helices (H1:128–140, H2:144–151,
H4:176–182), a 310-helix (H3:155–159), and four b-strands(S1:118–125, S2:162–166, S3:192–193, S4:198–205). A curved
antiparallel b-sheet is formed between the strands, with strand
order S2–S1–S4–S3. The concave side of the sheet partially
surrounds H4, whereas the other three helices are situated on
the convex side of the sheet.
This fold conforms closely to all those found for other mem-
bers of the parvulin type PPIase domains [5–12]. Surprisingly,
the structure of PrsA-PPI is most closely related to the crystal
structure of hPin1 [5], although PrsA does not prefer phos-
phorylated substrates like hPin1. The backbone atoms of their
secondary structure areas can be superimposed with an RMSD
of 0.9 A˚ (Fig. 2). The main structural diﬀerence resides in the
S1–H1 loop, a major determinant of hPin1 substrate speciﬁc-
ity. In hPin1 the loop contains seventeen residues and within
them a cluster of positively charged residues which forms the
recognition site for the phosphorylated Ser/Thr-Pro substrates
[5]. This loop is not present in PrsA, instead there is a two-res-
idue turn.
Residues taking part in prolyl isomerization [5,7], (corre-
sponding to H122, D154, L163, M172, F176, T194, and
H199 in PrsA) have positions similar to the other parvulin
structures. Again, a close similarity is observed between PrsA
and hPin1 (Fig. 2) with the exception of the orientation of
the two catalytic histidines. In PrsA-PPI the d1 protons of
the aromatic rings point towards each other whereas in hPin1
they point away from each other. Histidine sidechain orienta-
tion in PrsA-PPI is reminiscent to that found in the solution
structure of hPin1 [6].
3.3. Chemical shift mapping of the interaction surface
We performed titrations with three tetrapeptides (Suc-A-K/
Y/N-P-F-pNA) to characterize the substrate binding site of
PrsA-PPI. All observed chemical shift changes fell into the fast
exchange limit on NMR time scale, and all peak movements
Fig. 1. NMR solution structure of PrsA-PPI. (A) Ensemble of 15
energy minimized structures and (B) ribbon model of the structure
closest to the mean. In the ensemble, backbone atoms in areas of
regular secondary structure were superimposed. Secondary structure
elements are denoted.
Fig. 2. Superimposition of PrsA-PPI (red) and the PPIase domain of
hPin1 (blue, residues 54–163, PDB ID 1pin). Backbone atoms of
secondary structures were used in the ﬁt. Residues of the catalytic site
are highlighted.
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PPI. Very similar changes were observed for all three peptides
(see Fig. 3A). An average titration curve gave a dissociation
constant of 1.2 mM for Suc-AKPF-pNA. Those of the other
two peptides were in the same range, but the scarcity of the
titration points prevented a more accurate analysis.
The largest chemical shift perturbations for Suc-AKPF-
pNA (Fig. 3B) were detected for residues T153–D154 (in loop
H2–H3), S156–A157 (H3), F166 (S2), E169–E174 (loop S2–
H4), F176 (H4), and Q195–Y196 (loop S3–S4). All residues
perturbed by binding are located on the rims of a groove in
the PrsA-PPI structure (Fig. 3C), analogously to those found
for hPar14 [8] and Pin1At [10]. In hPar14 the residues experi-
encing the largest shifts were M90 (M172 in PrsA), V91
(D173), and F94 (F176). A larger binding epitope was found
for Pin1At also consisting of residues on the opposing rim of
the catalytic groove, as in PrsA-PPI.
S156 which resides in the binding site, showed an increase in
the T2 value in the protein–substrate complex, suggesting thatconformational exchange (Rex) decreased upon substrate bind-
ing. However, Rex still contributes to the T2 value signiﬁcantly
as S156 T2 is drastically lower than the average T2 value found
in the free form of PrsA-PPI.
The active site of PrsA-PPI is apolar (Fig. 3C), thus we
anticipate that it has the highest aﬃnity for substrates with
apolar sidechains. This is in contrast to the positively charged
pocket of the parvulins with speciﬁcity for phosphorylated
substrates and also in contrast with hPar14 that has negatively
charged sidechains partially responsible for Arg-Pro substrate
speciﬁcity [20]. In vitro protease-coupled enzymatic assay has
given the best Kcat/Km value of 15 mM
1 s1 for PrsA-PPI with
Suc-AKPF-pNA as substrate [1]. Despite PrsA did not show
enzymatic activity with two of the peptides (Suc-ANPF-pNA
and Suc-AYPF-pNA, data not shown), all the peptides in-
duced in PrsA-PPI similar chemical shift perturbations in
NMR titration experiments.
3.4. Mutants H122A and D154A
The H122A mutant is soluble but its 1H, 15N-HSQC spec-
trum shows the characteristics of an unfolded protein (data
not shown). Addition of Suc-AKPF-pNA did not alter the
spectrum. Thus, besides being required in the catalytic reaction
of parvulin PPIases [5], this residue is essential for correct fold-
ing of PrsA-PPI. This mutated PPIase domain did not show
any enhancement in the enzymatic activity with Suc-AKPF-
pNA as substrate [1], which is in good agreement with the
NMR data.
The 1H, 15N-HSQC spectrum of the D154A mutant has a
similar overall appearance to that of the wild type (wt) PrsA-
PPI. A closer examination reveals, however, that several peaks
are missing or have markedly shifted compared to the wt do-
main (T153, S156, D173, F176, S177, T194–Y196 and
Y198). All these residues either coincide with or are adjacent
Fig. 3. Characterization of the peptide binding site of PrsA-PPI. (A) Chemical shift changes observed upon binding of Suc-AKPF-pNA (black), Suc-
AYPF-pNA (grey) and Suc-ANPF-pNA (blue). Changes at PrsA-PPI to peptide molar ratio 1:16 are shown. (B) Residues signiﬁcantly perturbed
upon binding are highlighted on PrsA-PPI structure. Red codes for large (0.07 6 Dd < 0.36 ppm), and yellow for smaller (0.04 6 Dd < 0.07 ppm)
chemical shift changes. Backbone atoms of hPin1 (PDB ID 1pin) and PrsA-PPI were overlaid and the Ala-Pro dipeptide present in hPin1 structure is
shown in blue. (C) A molecular surface representations of PrsA-PPI coloured according to its electrostatic potential. Negative residues are coloured
in red, and positive in blue.
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ing that the structural perturbation in the mutant is restricted
to the binding site. Some of the changes are most likely due to
a change in the electrostatic contribution, but also some con-
formational changes must occur as several of the amide groups
are at a distance larger than 10 A˚ from the mutation site.
Relaxation data indicated that D154A is less stable than the
wt domain (data not shown). However, D154A is able to bind
a peptide substrate with a concomitant gain in stability. Bind-
ing of Suc-AKPF-pNA resulted in some peak shifts, those
which experienced the largest shifts are tentatively assigned
to D173 and E174. In agreement with the NMR data,
D154A exhibits about 50% of wild type PPIase activity
in vitro (Kcat/Km 6 mM
1 s1) [1]. In the parvulin family this
position is occupied by either aspartic acid or cysteine. InhPin1 a substitution of this residue (C113) either to alanine
or serine results in reduction of the activity by 123- and 20-
fold, respectively, [5]. The reduction in activity of PrsA is con-
siderably smaller than that of hPin1. It is conceivable that the
relative contribution of the proposed covalent mechanism in
the isomerization reaction is smaller for PrsA-PPI than for
some other members of the parvulin family [5,21].
In conclusion, we have determined the ﬁrst PPIase domain
structure from a Gram-positive bacterium. We have shown
that the PPIase domain of PrsA shares the common parvulin
fold with high structural similarity, but diﬀerent preferences
for substrates, in the active site. Designing a speciﬁc inhibitor
for the substrate binding site might provide new possibilities
for developing novel antimicrobial drugs against infections
caused by Gram-positive pathogens.
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